Mannose

(redirected from Mannosidases)
Also found in: Dictionary, Medical.

mannose

[′ma‚nōs]
(biochemistry)
C6H12O6 A fermentable monosaccharide obtained from manna.
McGraw-Hill Dictionary of Scientific & Technical Terms, 6E, Copyright © 2003 by The McGraw-Hill Companies, Inc.
The following article is from The Great Soviet Encyclopedia (1979). It might be outdated or ideologically biased.

Mannose

 

a monosaccharide of the general formula C6H12O6 (an isomer of glucose); a component of many polysaccharides and mixed biopolymers of plant, animal, and bacterial origin.

Mannose is readily soluble in water and has a sweet taste. Its melting point is 132°C Only the D-form occurs naturally. In its free form, mannose is present in many citrus fruits, as well as in fruits of the genera Anacardium and Corynocarpus. Mannose is converted in the organism with the help of its activated form, guanosine diphosphate mannose (GDPM), which serves as a mannose-radical donor in the synthesis of mannans and other biopolymers.

The Great Soviet Encyclopedia, 3rd Edition (1970-1979). © 2010 The Gale Group, Inc. All rights reserved.
References in periodicals archive ?
In addition, rER-mannosidase inhibitors could be used as an alternative approach, as fungal cells only contain one mannosidase class I within the rER, and its loss is associated with virulence attenuation 21].
Activity against [beta]-N acetylglucosamide and G mannopyranoside, using para nitrophenol (pNP) conjugates showed that chlamydia expressed high levels of [beta]-N acetylglucosaminidase and G mannosidase. These glycosides are components of hyaluronic acid found as extracellular matrix and mannosyl phosphodolichol, found in endoplasmic reticulum respectively.
The interaction found between rs4235144 and rs9489622 is located within the gene gamma-aminobutyric acid type A receptor beta1 subunit (GABRB1) and the gene mannosidase alpha class 1A member 1 (MAN1A1).
reesei transcriptome between wheat straw and lactose is the wheat straw specific chitinases and mannosidase, which were significantly higher expressed in an xyr1-deletion strain [65].
Huxtable and Dorling (1985) observed that rats treated with high doses of swainsonine (about 15 mg/day) for 100-200 days developed neuronal mannosidase storage disease only in areas of the brain not protected by the blood/brain barrier.